帕唑帕尼

规格或纯度: ≥99%

CAS编号: 444731-52-6
分子式: C₂₁H₂₃N₇O₂S
分子量: 437.53
PubChem编号: 10113978

有货

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭

货号 (SKU)	包装规格	是否现货
P125184-25mg	25mg	现货
P125184-100mg	100mg	现货
P125184-500mg	500mg	现货
P125184-1g	1g	现货
P125184-5g	5g	现货
P125184-25g	25g	现货

查看相关系列

colony stimulating factor 1 receptor Inhibitor fibroblast growth factor receptor 1 Inhibitor fms related receptor tyrosine kinase 1 Inhibitor fms related receptor tyrosine kinase 4 Inhibitor kinase insert domain receptor Inhibitor KIT proto-oncogene，receptor tyrosine kinase Inhibitor platelet derived growth factor receptor beta Inhibitor

Skip to the end of the images gallery

Skip to the beginning of the images gallery

基本描述

别名	VEGFR抑制剂\|帕唑帕尼
英文别名	Pazopanib\|444731-52-6\|GW786034\|pazopanibum\|5-((4-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonamide\|GW 786034\|UNII-7RN5DR86CK\|7RN5DR86CK\|NSC-752782\|790713-33-6\|DTXSID8048733\|GW 78603\|CHEBI:71219\|indazolylpyrimidi
规格或纯度	≥99%
英文名称	Pazopanib
生化机理	Pazopanib is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFR, FGFR, c-Kit and c-Fms with IC50 of 10 nM, 30 nM, 47 nM, 84 nM, 74 nM, 140 nM and 146 nM, respectively.
储存温度	-20°C储存
运输条件	超低温冰袋运输
产品介绍	Pazopanib is a potent and selective multi-targeted tyrosine kinase inhibitor that targets vascular endothelial growth factor receptor (Flk-1), platelet-derived growth factor receptor (PDGFR) and c-kit, which are key proteins responsible for tumor growth and angiogenesis.A potent and selective inhibitor of Flk-1, PDGFR and c-kit Pazopanib is a potent and selective multi-targeted tyrosine kinase inhibitor that targets vascular endothelial growth factor receptor (Flk-1), platelet-derived growth factor receptor (PDGFR) and c-kit, which are key proteins responsible for tumor growth and angiogenesis. A potent and selective inhibitor of Flk-1, PDGFR and c-kit

名称和标识符

IUPAC Name	5-[[4-[(2,3-dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide
INCHI	InChI=1S/C21H23N7O2S/c1-13-5-6-15(11-19(13)31(22,29)30)24-21-23-10-9-20(25-21)27(3)16-7-8-17-14(2)28(4)26-18(17)12-16/h5-12H,1-4H3,(H2,22,29,30)(H,23,24,25)
InChi Key	CUIHSIWYWATEQL-UHFFFAOYSA-N
Canonical SMILES	CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N
Isomeric SMILES	CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N
PubChem CID	10113978
分子量	437.53

数据库链接

CAS Registry No.	444731-52-6
Wikipedia	Pazopanib
DiscoveRx TREEspot	Pazopanib\|
PubChem CID	10113978
ChEMBL Ligand	CHEMBL477772
PEP	pazopanib
Reactome Reaction	R-HSA-9674427, R-HSA-9674093, R-HSA-2077424, R-HSA-9693978, R-HSA-2029992
Reactome Drug	R-ALL-9616920
DrugCentral Ligand	4118

CAS Registry No.

444731-52-6

Wikipedia

Pazopanib

DiscoveRx TREEspot

Pazopanib|

PubChem CID

10113978

ChEMBL Ligand

CHEMBL477772

PEP

pazopanib

Reactome Reaction

R-HSA-9674427, R-HSA-9674093, R-HSA-2077424, R-HSA-9693978, R-HSA-2029992

Reactome Drug

R-ALL-9616920

DrugCentral Ligand

4118

溶解性	DMSO 88 mg/mL Water <1 mg/mL Ethanol <1 mg/mL

相关文档

产品问答

登录提交问题

查看全部

您提交该产品问题后,我们会在1-2个工作日内给您答复,您可以登录"我的账号",然后点击"我的产品问答"查看答案

参考文献

1. Harris PA, Cheung M, Hunter 3rd RN, Brown ML, Veal JM, Nolte RT, Wang L, Liu W, Crosby RM, Johnson JH et al.. (2005) Discovery and evaluation of 2-anilino-5-aryloxazoles as a novel class of VEGFR2 kinase inhibitors.. J Med Chem, 48 (5): (1610-9). [PMID:15743202]
2. Harris PA, Boloor A, Cheung M, Kumar R, Crosby RM, Davis-Ward RG, Epperly AH, Hinkle KW, Hunter 3rd RN, Johnson JH et al.. (2008) Discovery of 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a novel and potent vascular endothelial growth factor receptor inhibitor.. J Med Chem, 51 (15): (4632-40). [PMID:18620382]

帕唑帕尼

库存信息

库存信息

库存信息

库存信息

库存信息

库存信息

基本描述

名称和标识符

数据库链接

化学和物理性质

质检证书(COA)

质检报告(COA)

相关文档

质检报告COA

产品问答

产品问答

参考文献